Many studies reported that the IL1R2 as a protected factor can decrease the risk of many diseases, such as IgA nephropathy (Xie et al., 2017), Arthritis (Shimizu et al., 2015), and atherosclerosis (Pou et al., 2011). This evidence concerns the gene IL1R2 and IgA glomerulonephritis.